Concepts (277)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Ganglion Cells | 16 | 2025 | 111 | 5.290 |
Why?
|
| Intraocular Pressure | 18 | 2025 | 125 | 4.950 |
Why?
|
| Glaucoma | 10 | 2025 | 79 | 3.830 |
Why?
|
| Ocular Hypertension | 6 | 2025 | 26 | 3.080 |
Why?
|
| Retinal Degeneration | 4 | 2024 | 97 | 1.500 |
Why?
|
| Color Vision | 3 | 2020 | 11 | 1.330 |
Why?
|
| Retina | 10 | 2025 | 445 | 1.210 |
Why?
|
| Disease Models, Animal | 11 | 2025 | 4445 | 0.990 |
Why?
|
| Nerve Degeneration | 2 | 2018 | 128 | 0.940 |
Why?
|
| Optic Nerve Diseases | 2 | 2018 | 78 | 0.910 |
Why?
|
| Intracranial Hypertension | 2 | 2018 | 129 | 0.900 |
Why?
|
| Retinal Vessels | 2 | 2025 | 52 | 0.880 |
Why?
|
| Ophthalmologists | 1 | 2023 | 11 | 0.830 |
Why?
|
| Contrast Sensitivity | 3 | 2020 | 33 | 0.810 |
Why?
|
| Glaucoma, Open-Angle | 4 | 2021 | 35 | 0.810 |
Why?
|
| Virtual Reality | 1 | 2023 | 34 | 0.800 |
Why?
|
| Color Perception | 1 | 2022 | 11 | 0.740 |
Why?
|
| Dark Adaptation | 3 | 2016 | 33 | 0.700 |
Why?
|
| Amacrine Cells | 2 | 2020 | 42 | 0.690 |
Why?
|
| Adaptation, Ocular | 1 | 2020 | 18 | 0.670 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 103 | 0.660 |
Why?
|
| Diabetic Retinopathy | 4 | 2024 | 83 | 0.660 |
Why?
|
| Light | 2 | 2020 | 165 | 0.660 |
Why?
|
| Capillaries | 1 | 2020 | 67 | 0.660 |
Why?
|
| Mice, Inbred C57BL | 9 | 2025 | 4514 | 0.640 |
Why?
|
| Regional Blood Flow | 1 | 2020 | 193 | 0.640 |
Why?
|
| Neuroprotective Agents | 2 | 2019 | 155 | 0.630 |
Why?
|
| Electroretinography | 4 | 2025 | 106 | 0.570 |
Why?
|
| Aging | 1 | 2025 | 1208 | 0.550 |
Why?
|
| Vision, Ocular | 1 | 2019 | 124 | 0.550 |
Why?
|
| Trabeculectomy | 2 | 2020 | 17 | 0.550 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 90 | 0.540 |
Why?
|
| Neuroprotection | 1 | 2018 | 29 | 0.540 |
Why?
|
| Drosophila Proteins | 7 | 2008 | 756 | 0.530 |
Why?
|
| Action Potentials | 2 | 2019 | 463 | 0.510 |
Why?
|
| Optic Nerve | 1 | 2018 | 108 | 0.510 |
Why?
|
| Photoreceptor Cells, Invertebrate | 5 | 2008 | 58 | 0.500 |
Why?
|
| Nerve Fibers | 4 | 2024 | 67 | 0.490 |
Why?
|
| Tonometry, Ocular | 5 | 2022 | 29 | 0.490 |
Why?
|
| Nuclear Proteins | 6 | 2008 | 1206 | 0.490 |
Why?
|
| Animals | 25 | 2025 | 33205 | 0.490 |
Why?
|
| Tomography, Optical Coherence | 6 | 2024 | 441 | 0.480 |
Why?
|
| Medical Staff, Hospital | 1 | 2016 | 93 | 0.480 |
Why?
|
| ErbB Receptors | 3 | 2007 | 287 | 0.480 |
Why?
|
| Mice | 13 | 2025 | 17693 | 0.470 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2015 | 11 | 0.470 |
Why?
|
| Paraproteinemias | 1 | 2015 | 21 | 0.460 |
Why?
|
| Cell Count | 4 | 2016 | 218 | 0.440 |
Why?
|
| Filtering Surgery | 1 | 2013 | 3 | 0.410 |
Why?
|
| Transcription Factors | 6 | 2008 | 2345 | 0.410 |
Why?
|
| Silver | 1 | 2013 | 27 | 0.400 |
Why?
|
| Metal Nanoparticles | 1 | 2013 | 54 | 0.390 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2013 | 68 | 0.390 |
Why?
|
| Eye Diseases | 2 | 2025 | 104 | 0.390 |
Why?
|
| Drosophila melanogaster | 5 | 2006 | 808 | 0.380 |
Why?
|
| Transcriptome | 1 | 2019 | 1069 | 0.370 |
Why?
|
| Retinal Diseases | 1 | 2013 | 145 | 0.340 |
Why?
|
| Female | 21 | 2026 | 68733 | 0.290 |
Why?
|
| Night Vision | 2 | 2020 | 6 | 0.280 |
Why?
|
| Eye | 4 | 2006 | 222 | 0.280 |
Why?
|
| Ectropion | 1 | 2007 | 5 | 0.280 |
Why?
|
| Retinal Detachment | 2 | 2026 | 36 | 0.260 |
Why?
|
| Quinazolines | 1 | 2007 | 179 | 0.250 |
Why?
|
| Internship and Residency | 1 | 2016 | 1198 | 0.240 |
Why?
|
| Cell Differentiation | 6 | 2006 | 1871 | 0.240 |
Why?
|
| Homeodomain Proteins | 2 | 2026 | 539 | 0.240 |
Why?
|
| Cell Survival | 2 | 2020 | 840 | 0.230 |
Why?
|
| Blood-Retinal Barrier | 1 | 2025 | 3 | 0.230 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2008 | 247 | 0.230 |
Why?
|
| Drosophila | 3 | 2008 | 767 | 0.220 |
Why?
|
| Skin | 1 | 2007 | 517 | 0.220 |
Why?
|
| Pupa | 1 | 2004 | 21 | 0.220 |
Why?
|
| Vision Disorders | 2 | 2017 | 188 | 0.210 |
Why?
|
| Cell Cycle Proteins | 3 | 2008 | 677 | 0.210 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2014 | 96 | 0.210 |
Why?
|
| Axial Length, Eye | 2 | 2014 | 35 | 0.210 |
Why?
|
| Diabetes Mellitus | 2 | 2021 | 873 | 0.200 |
Why?
|
| Weightlessness | 1 | 2025 | 81 | 0.200 |
Why?
|
| Papilledema | 1 | 2025 | 80 | 0.200 |
Why?
|
| Male | 15 | 2026 | 62861 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 576 | 0.200 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 1892 | 0.200 |
Why?
|
| Phenotype | 3 | 2025 | 4309 | 0.200 |
Why?
|
| Macula Lutea | 1 | 2022 | 25 | 0.190 |
Why?
|
| Biomarkers | 3 | 2019 | 3252 | 0.190 |
Why?
|
| Color | 1 | 2022 | 32 | 0.180 |
Why?
|
| Acceleration | 1 | 2022 | 24 | 0.180 |
Why?
|
| Physician's Role | 1 | 2023 | 163 | 0.180 |
Why?
|
| Peripheral Nervous System | 1 | 2002 | 45 | 0.180 |
Why?
|
| Space Flight | 1 | 2025 | 166 | 0.180 |
Why?
|
| Cell Nucleus | 1 | 2004 | 552 | 0.180 |
Why?
|
| Insect Proteins | 1 | 2001 | 99 | 0.170 |
Why?
|
| Mutation, Missense | 1 | 2026 | 890 | 0.170 |
Why?
|
| Puromycin | 1 | 2020 | 12 | 0.170 |
Why?
|
| Neuronal Outgrowth | 1 | 2020 | 5 | 0.170 |
Why?
|
| Ophthalmology | 1 | 2023 | 175 | 0.170 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2020 | 7 | 0.170 |
Why?
|
| Corneal Edema | 1 | 2020 | 11 | 0.170 |
Why?
|
| beta-Alanine | 1 | 2020 | 7 | 0.170 |
Why?
|
| Pseudotumor Cerebri | 1 | 2022 | 63 | 0.170 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2020 | 85 | 0.170 |
Why?
|
| Humans | 24 | 2026 | 127455 | 0.170 |
Why?
|
| Benzoates | 1 | 2020 | 26 | 0.170 |
Why?
|
| rho-Associated Kinases | 1 | 2020 | 47 | 0.160 |
Why?
|
| Electrophysiology | 1 | 2020 | 252 | 0.160 |
Why?
|
| Photic Stimulation | 1 | 2020 | 211 | 0.160 |
Why?
|
| Epithelium, Corneal | 1 | 2020 | 171 | 0.150 |
Why?
|
| Suppression, Genetic | 2 | 1995 | 41 | 0.140 |
Why?
|
| Gout | 1 | 2021 | 170 | 0.140 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 1759 | 0.140 |
Why?
|
| Veterans | 2 | 2021 | 1742 | 0.140 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2020 | 259 | 0.140 |
Why?
|
| Aqueous Humor | 1 | 2017 | 17 | 0.140 |
Why?
|
| Microscopy, Electron | 1 | 2018 | 309 | 0.130 |
Why?
|
| Antihypertensive Agents | 2 | 2023 | 416 | 0.130 |
Why?
|
| Meningeal Carcinomatosis | 1 | 2017 | 2 | 0.130 |
Why?
|
| Repressor Proteins | 1 | 2001 | 764 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1601 | 0.130 |
Why?
|
| Cancer Care Facilities | 1 | 2017 | 33 | 0.130 |
Why?
|
| Cell Death | 2 | 2017 | 237 | 0.120 |
Why?
|
| Genes, src | 2 | 1995 | 3 | 0.120 |
Why?
|
| Aged | 10 | 2026 | 20494 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 417 | 0.120 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 272 | 0.120 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 247 | 0.120 |
Why?
|
| Middle Aged | 9 | 2026 | 27867 | 0.120 |
Why?
|
| Up-Regulation | 1 | 2018 | 827 | 0.120 |
Why?
|
| Thymus Hormones | 1 | 1995 | 2 | 0.110 |
Why?
|
| Photophobia | 1 | 2015 | 8 | 0.110 |
Why?
|
| Tubulin | 1 | 2015 | 67 | 0.110 |
Why?
|
| Retinal Neurons | 1 | 2015 | 13 | 0.110 |
Why?
|
| Cells, Cultured | 1 | 2020 | 2899 | 0.110 |
Why?
|
| Sensory Thresholds | 1 | 2014 | 32 | 0.110 |
Why?
|
| Signal Transduction | 2 | 2004 | 4489 | 0.110 |
Why?
|
| Ribonucleoproteins | 1 | 1995 | 57 | 0.110 |
Why?
|
| Hospitals, Veterans | 1 | 2016 | 341 | 0.110 |
Why?
|
| Visual Fields | 1 | 2015 | 133 | 0.110 |
Why?
|
| Intracranial Pressure | 1 | 2015 | 200 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 361 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 1055 | 0.100 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2017 | 692 | 0.100 |
Why?
|
| Blister | 1 | 2013 | 20 | 0.100 |
Why?
|
| Mitomycin | 1 | 2013 | 48 | 0.100 |
Why?
|
| Administration, Topical | 1 | 2013 | 131 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2008 | 979 | 0.100 |
Why?
|
| Viral Proteins | 1 | 1995 | 336 | 0.100 |
Why?
|
| Biotin | 1 | 2013 | 39 | 0.100 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 123 | 0.100 |
Why?
|
| Rabbits | 1 | 2013 | 626 | 0.090 |
Why?
|
| Axons | 1 | 2015 | 373 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 6716 | 0.090 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 1148 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2013 | 954 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 1600 | 0.090 |
Why?
|
| Transcription, Genetic | 2 | 1995 | 1382 | 0.080 |
Why?
|
| Algorithms | 1 | 2017 | 1638 | 0.080 |
Why?
|
| Eye Neoplasms | 1 | 2010 | 38 | 0.080 |
Why?
|
| Electronic Health Records | 1 | 2017 | 781 | 0.080 |
Why?
|
| Vascular Neoplasms | 1 | 2010 | 32 | 0.080 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2010 | 40 | 0.080 |
Why?
|
| Adult | 7 | 2026 | 30579 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2016 | 1021 | 0.080 |
Why?
|
| Disease Progression | 1 | 2015 | 2125 | 0.070 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2010 | 152 | 0.070 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2007 | 15 | 0.070 |
Why?
|
| Carcinoma, Small Cell | 1 | 2007 | 39 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2023 | 17076 | 0.070 |
Why?
|
| Streptococcus pyogenes | 2 | 1998 | 80 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2026 | 3331 | 0.060 |
Why?
|
| Karyopherins | 1 | 2006 | 35 | 0.060 |
Why?
|
| Cicatrix | 1 | 2007 | 122 | 0.060 |
Why?
|
| Streptococcal Infections | 2 | 1998 | 247 | 0.060 |
Why?
|
| Mutation | 5 | 2008 | 5948 | 0.060 |
Why?
|
| Metamorphosis, Biological | 1 | 2004 | 7 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 3694 | 0.050 |
Why?
|
| Astronauts | 1 | 2025 | 77 | 0.050 |
Why?
|
| Whole Genome Sequencing | 1 | 2026 | 320 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2004 | 126 | 0.050 |
Why?
|
| Bimatoprost | 1 | 2023 | 2 | 0.050 |
Why?
|
| Cloprostenol | 1 | 2023 | 4 | 0.050 |
Why?
|
| Heterozygote | 1 | 2026 | 691 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2003 | 76 | 0.050 |
Why?
|
| Ophthalmic Solutions | 1 | 2023 | 84 | 0.050 |
Why?
|
| Amides | 1 | 2023 | 89 | 0.050 |
Why?
|
| Molecular Sequence Data | 4 | 2008 | 3588 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2004 | 324 | 0.050 |
Why?
|
| Eye Proteins | 1 | 2003 | 229 | 0.050 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 2022 | 17 | 0.050 |
Why?
|
| Neuroglia | 1 | 2004 | 208 | 0.050 |
Why?
|
| Syndrome | 1 | 2025 | 1137 | 0.050 |
Why?
|
| Animals, Genetically Modified | 3 | 2008 | 325 | 0.040 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 58 | 0.040 |
Why?
|
| United Kingdom | 1 | 2021 | 235 | 0.040 |
Why?
|
| Slit Lamp Microscopy | 1 | 2020 | 4 | 0.040 |
Why?
|
| Glaucoma Drainage Implants | 1 | 2020 | 9 | 0.040 |
Why?
|
| Descemet Stripping Endothelial Keratoplasty | 1 | 2020 | 10 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 588 | 0.040 |
Why?
|
| Base Sequence | 3 | 2008 | 2760 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2006 | 1057 | 0.040 |
Why?
|
| Corneal Diseases | 1 | 2020 | 92 | 0.040 |
Why?
|
| Cataract Extraction | 1 | 2020 | 125 | 0.040 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2020 | 173 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2026 | 1730 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 6249 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 538 | 0.040 |
Why?
|
| 3T3 Cells | 2 | 1995 | 120 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 1100 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 1493 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2020 | 501 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 1995 | 435 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2026 | 2752 | 0.030 |
Why?
|
| Carrier State | 1 | 1997 | 80 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2008 | 270 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 592 | 0.030 |
Why?
|
| Genes, Regulator | 1 | 1995 | 43 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 1995 | 11 | 0.030 |
Why?
|
| Cations | 1 | 2015 | 37 | 0.030 |
Why?
|
| Electron Transport Complex IV | 1 | 1995 | 40 | 0.030 |
Why?
|
| Sequence Homology | 1 | 1995 | 59 | 0.030 |
Why?
|
| Heterogeneous Nuclear Ribonucleoprotein A1 | 1 | 1995 | 9 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2026 | 3269 | 0.030 |
Why?
|
| A Kinase Anchor Proteins | 1 | 1995 | 21 | 0.030 |
Why?
|
| Retinal Bipolar Cells | 1 | 2015 | 40 | 0.030 |
Why?
|
| Chloride Channels | 1 | 2015 | 60 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 1995 | 106 | 0.030 |
Why?
|
| Mitosis | 1 | 1995 | 190 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1995 | 297 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1995 | 198 | 0.030 |
Why?
|
| Neurons | 1 | 2004 | 1922 | 0.030 |
Why?
|
| DNA Helicases | 1 | 1995 | 229 | 0.030 |
Why?
|
| Collagen | 1 | 1995 | 292 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 2999 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2017 | 1195 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1867 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 1485 | 0.020 |
Why?
|
| Synapses | 1 | 2015 | 433 | 0.020 |
Why?
|
| Antigens, CD20 | 1 | 2010 | 40 | 0.020 |
Why?
|
| Retinal Hemorrhage | 1 | 2010 | 18 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 2893 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2010 | 101 | 0.020 |
Why?
|
| Paraplegia | 1 | 2010 | 88 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 1374 | 0.020 |
Why?
|
| Proteins | 1 | 1995 | 1019 | 0.020 |
Why?
|
| Risk Factors | 2 | 2021 | 10631 | 0.020 |
Why?
|
| Lacrimal Apparatus | 1 | 2010 | 124 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 1995 | 1709 | 0.020 |
Why?
|
| DNA Probes | 1 | 2008 | 120 | 0.020 |
Why?
|
| Genes, Insect | 1 | 2008 | 112 | 0.020 |
Why?
|
| Body Patterning | 1 | 2008 | 128 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 2 | 1998 | 92 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2008 | 184 | 0.020 |
Why?
|
| Serotyping | 2 | 1998 | 172 | 0.020 |
Why?
|
| Minnesota | 2 | 1998 | 177 | 0.020 |
Why?
|
| Biopsy | 1 | 2010 | 1237 | 0.020 |
Why?
|
| Cilia | 1 | 2006 | 76 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2003 | 2543 | 0.010 |
Why?
|
| Rhodopsin | 1 | 2004 | 66 | 0.010 |
Why?
|
| Larva | 1 | 2004 | 249 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2003 | 281 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 1561 | 0.010 |
Why?
|
| United States | 1 | 2017 | 11399 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 1538 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 3720 | 0.010 |
Why?
|
| Fasciitis, Necrotizing | 1 | 1998 | 29 | 0.010 |
Why?
|
| Pharyngitis | 1 | 1997 | 34 | 0.010 |
Why?
|
| Molecular Epidemiology | 1 | 1997 | 145 | 0.010 |
Why?
|
| Virulence | 1 | 1997 | 270 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 1997 | 216 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 1997 | 410 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 1995 | 29 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 1997 | 482 | 0.010 |
Why?
|
| Genes, ras | 1 | 1995 | 99 | 0.010 |
Why?
|
| Disease Outbreaks | 1 | 1997 | 308 | 0.010 |
Why?
|
| Schools | 1 | 1997 | 235 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1995 | 565 | 0.010 |
Why?
|
| Rats | 1 | 1995 | 3397 | 0.000 |
Why?
|
| Child | 1 | 1997 | 25296 | 0.000 |
Why?
|